Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023

BUY
$0.51 - $17.1 $4,080 - $136,800
8,000 Added 22.38%
43,740 $31,000
Q2 2022

Aug 10, 2022

SELL
$0.54 - $1.41 $843 - $2,202
-1,562 Reduced 4.19%
35,740 $36,000
Q1 2022

May 12, 2022

BUY
$1.4 - $5.15 $28,000 - $103,000
20,000 Added 115.59%
37,302 $53,000
Q4 2021

Feb 10, 2022

BUY
$4.27 - $6.97 $1,707 - $2,788
400 Added 2.37%
17,302 $91,000
Q3 2021

Nov 12, 2021

SELL
$5.31 - $8.25 $54,204 - $84,216
-10,208 Reduced 37.65%
16,902 $98,000
Q2 2021

Aug 06, 2021

BUY
$6.81 - $9.23 $184,619 - $250,225
27,110 New
27,110 $217,000
Q1 2020

May 21, 2020

SELL
$4.62 - $18.74 $49,937 - $202,560
-10,809 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$14.6 - $18.13 $157,811 - $195,967
10,809 New
10,809 $183,000
Q3 2019

Nov 12, 2019

SELL
$16.62 - $23.92 $210,857 - $303,473
-12,687 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$17.79 - $22.88 $50,078 - $64,407
2,815 Added 28.51%
12,687 $289,000
Q1 2019

May 15, 2019

BUY
$11.76 - $22.15 $116,094 - $218,664
9,872 New
9,872 $207,000
Q4 2018

Feb 14, 2019

SELL
$10.42 - $21.94 $109,222 - $229,975
-10,482 Closed
0 $0
Q3 2018

Nov 09, 2018

BUY
$20.4 - $24.6 $12,444 - $15,006
610 Added 6.18%
10,482 $240,000
Q2 2018

Aug 14, 2018

SELL
$19.02 - $24.95 $13,028 - $17,090
-685 Reduced 6.49%
9,872 $220,000
Q1 2018

May 15, 2018

BUY
$22.55 - $29.9 $27,060 - $35,880
1,200 Added 12.82%
10,557 $241,000
Q4 2017

Feb 14, 2018

BUY
$18.0 - $30.0 $168,426 - $280,710
9,357 New
9,357 $246,000
Q3 2017

Nov 14, 2017

SELL
$21.1 - $25.15 $173,547 - $206,858
-8,225 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
8,225
8,225 $226,000

Others Institutions Holding AXDX

About Accelerate Diagnostics, Inc


  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $168M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.